卵巣がん患者における異変的に成長する転移の間の異質な腫瘍-免疫マイクロ環境
Alejandro Jiménez-Sánchez1, Danish Memon2, Stephane Pourpe3
1Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.
Cell
|August 26, 2017
まとめ
卵巣がんでは,異なる腫瘍免疫マイクロ環境が共存し,治療に対する異なった転移性病変の反応を説明します. 免疫ゲノミクスは 免疫細胞の浸透を 退行する腫瘍と 進行する腫瘍の排除を 明らかにしています
科学分野:
- 腫瘍学
- 免疫学
- ゲノミクス
背景:
- 高度な血清性卵巣がん (HGSOC) は,しばしば複数の化学療法療法療法で治療されます.
- 転移性病変は治療に対する異質な反応を示し,あるものは進行し,あるものは後退する.
関連する概念動画
The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Metastasis
6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K


